Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to allow the continuation of everolimus treatment in patients
who have completed the core study (NCT00170885) and to collect long-term safety,
tolerability, and efficacy data in a group of patients treated with the upper everolimus
target levels plus very low dose cyclosporin in comparison with the standard everolimus
target levels plus low dose cyclosporin in patients with renal transplantation.